OATP1B1-MEDIATED HEPATIC UPTAKE OF SN-38, AN ACTIVE METABOLITE OF IRINOTECAN, AND ITS INHIBITION BY UREMIC TOXINS IN HUMANS

被引：0
|
作者：
Fujita, K. [1 ]
Sugiura, T. [2 ]
Okumura, H. [2 ]
Umeda, S. [2 ]
Nakamichi, N. [2 ]
Sasaki, Y. [1 ]
Kato, Y. [2 ]
机构：
[1] Saitama Med Univ, Hidaka, Japan
[2] Kanazawa Univ, Kanazawa, Ishikawa, Japan
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [21] Cellular uptake and toxicity of irinotecan and its active metabolite, SN-38 in hamster intestine and human colon cancer cells
    Matsuzaki, Y
    Kobayashi, K
    Bouscarel, B
    Ceryak, S
    Jordan, T
    Fromm, H
    Kudoh, S
    Tanaka, N
    GASTROENTEROLOGY, 1999, 116 (04) : A906 - A906
  • [22] LIMITED SAMPLING MODELS FOR SIMULTANEOUS ESTIMATION OF THE PHARMACOKINETICS OF IRINOTECAN AND ITS ACTIVE METABOLITE SN-38
    CHABOT, GG
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 36 (06) : 463 - 472
  • [23] Role of Mrp3-mediated efflux in systemic exposure of SN-38, the active metabolite of irinotecan
    Kitamura, Yoshiaki
    Kusuhara, Hiroyuki
    Sugiyama, Yuichi
    DRUG METABOLISM REVIEWS, 2010, 42 : 288 - 288
  • [24] Assessment of exposure risk of irinotecan and its active metabolite, SN-38, through perspiration during chemotherapy
    Irie, Kei
    Okada, Akira
    Masuda, Yoshio
    Fukushima, Keizo
    Sugioka, Nobuyuki
    Okuda, Chiyuki
    Hata, Akito
    Kaji, Reiko
    Okada, Yutaka
    Katakami, Nobuyuki
    Fukushima, Shoji
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (04) : 865 - 868
  • [25] Uptake mechanism of irinotecan (CPT-11) and its metabolite (SN-38) by hamster intestinal cells.
    Kobayashi, K
    Bouscarel, B
    Matsuzaki, Y
    Ceryak, S
    Fromm, H
    GASTROENTEROLOGY, 1998, 114 (04) : A626 - A627
  • [26] OATP1A/1B Transporters Affect Irinotecan and SN-38 Pharmacokinetics and Carboxylesterase Expression in Knockout and Humanized Transgenic Mice
    Iusuf, Dilek
    Ludwig, Marion
    Elbatsh, Ahmed
    van Esch, Anita
    van de Steeg, Evita
    Wagenaar, Els
    van der Valk, Martin
    Lin, Fan
    van Tellingen, Olaf
    Schinkel, Alfred H.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (02) : 492 - 503
  • [27] P-glycoprotein-dependent pharmacokinetics of irinotecan and its active metabolite, SN-38 in rats: Effect of verapamil
    Garg, Tripta
    Jaggi, Manu
    Khar, Roop K.
    Talegaonkar, Sushama
    ADMET AND DMPK, 2015, 3 (01): : 68 - 76
  • [28] Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients
    Karas, Spinel
    Etheridge, Amy S.
    Tsakalozou, Eleftheria
    Ramirez, Jacqueline
    Cecchin, Erika
    van Schaik, Ron H. N.
    Toffoli, Giuseppe
    Ratain, Mark J.
    Mathijssen, Ron H. J.
    Forrest, Alan
    Bies, Robert R.
    Innocenti, Federico
    AAPS JOURNAL, 2020, 22 (03):
  • [29] Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients
    Spinel Karas
    Amy S. Etheridge
    Eleftheria Tsakalozou
    Jacqueline Ramírez
    Erika Cecchin
    Ron H.N. van Schaik
    Giuseppe Toffoli
    Mark J. Ratain
    Ron H.J. Mathijssen
    Alan Forrest
    Robert R. Bies
    Federico Innocenti
    The AAPS Journal, 22
  • [30] Long-Lasting Inhibitory Effects of Saquinavir and Ritonavir on OATP1B1-Mediated Uptake
    Shitara, Yoshihisa
    Takeuchi, Kumiko
    Horie, Toshiharu
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (09) : 3427 - 3435
12345